Navigation Links
Media Advisory - Oncolytics Biotech Inc. to Present at BioSquare 2008
Date:3/10/2008

CALGARY, March 10 /PRNewswire-FirstCall/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will present a corporate overview of the Company at the BioSquare 2008 Conference on Thursday, March 13, 2008. The event is being held at the Congress Center in Basel, Switzerland from March 12-14, 2008.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I/II and Phase II human trials using REOLYSIN(R), its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about Oncolytics, please visit http://www.oncolyticsbiotech.com

The presentation times are subject to change. This release and the presentation related thereto contain forward-looking statements which involve known and unknown risks, delays, uncertainties and other factors not under the Company's control and which may cause actual results, performance or achievements of the Company to be materially different from the results, performance or expectations implied by these forward-looking statements. Such risks and uncertainties include, among others, the efficacy of REOLYSIN(R) as a cancer treatment, the success and timely completion of clinical studies and trials, uncertainties related to the research and development of pharmaceuticals and uncertainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue reliance on forward-looking statements. The Company does not undertake to update these forward-looking statemen
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. AUDIO from Medialink and GlaxoSmithKline: Fiber Key in Managing Irritable Bowel Syndrome (IBS) Symptoms
2. Mediatech Moves to Prince William County Innovation Park
3. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
4. Media Advisory - Oncolytics Biotech Inc. to Present at BIO InvestorForum 2007
5. Monsanto Company Sets Webcast and Analyst/Media Call for 2007 Fourth-Quarter and Fiscal-Year Financial Results
6. AUDIO from Medialink and Pfizer: Hispanic Heritage Month Reminds Us Increasing Numbers of Hispanic-Americans Do Not Have Health Insurance
7. CompareNetworks Media Group Delivers CME/CE Through Acuity Medical Education
8. Media Advisory - Oncolytics Biotech Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
10. Scientists Using Social Media to Inform Lab Purchasing Decisions
11. NEWSWEEK: Media Lead Sheet/December 10, 2007 Issue (on newsstands Monday, December 3).

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...IJING, Nov. 25 /PRNewswire-Asia/ -- Sinovac Biotec... vaccines, announced today that it executed,a join...ian) Vaccine,Technology Co., Ltd. (Sinovac Dalian)...rcialize human-use vaccines. Sinovac will contribu...commercializing world-class vaccines; the,other pa...
(Date:11/24/2009)...ble in German . , Whether it,s CD packaging...adio Frequency Identification) are increasingly fi...ossible to label objects or goods and identify the...e scanner can read and process the data contained ... under production conditions of up to 100 degrees ...
(Date:11/24/2009)... The New York investment bank KTA Capital,s client...n AU$6.7 mil convertible note private placement wi...ement was arranged by KTA Capital as Neuren,s excl... New York (PRWEB) November 23, 2009 -- ...al, LLC ("KTA Capital") has announced th...
(Date:11/24/2009)... REYKJAVIK, Iceland, November 24 /PRNewswire-Fi...today announced that it has received notice from,t...,s common stock will be,suspended as of November 3...ecurities and Exchange Commission, which will remo...nless the company files an appeal to the Nasdaq,Li...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Intelligence inside metal components 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3
...ly 30 Anadys Pharmaceuticals,Inc. (Nasdaq: ANDS ...cated,to improving patient care by developing nove...gy, today reported its financial results and,highl... "The first half of 2008 has been a remarkably pr...., President and CEO. "Through the focused,efforts...
... major innovation in adaptive and assistive techno...ly 30 /PRNewswire/ - Touch,Bionics, developer of t...d,today announced that the i-LIMB Hand has won a 2...rosis Society., The da Vinci Awards recognize the...tive and assistive technology. The National Multip...
... In an announcement by Ronald Flynn, ...ortium, he stated that the agreement made would al...directly to countries, cities, and governmental en...ndfills and dumpsites. , ...rum Blue Steel Corporation announced today the for...
Other Biology Technology:Anadys Pharmaceuticals Reports Second Quarter 2008 Financial Results and Highlights 2Anadys Pharmaceuticals Reports Second Quarter 2008 Financial Results and Highlights 3Anadys Pharmaceuticals Reports Second Quarter 2008 Financial Results and Highlights 4Anadys Pharmaceuticals Reports Second Quarter 2008 Financial Results and Highlights 5Anadys Pharmaceuticals Reports Second Quarter 2008 Financial Results and Highlights 6Anadys Pharmaceuticals Reports Second Quarter 2008 Financial Results and Highlights 7Touch Bionics a 2008 da Vinci Award winner 2Geecf: Spectrum Blue Steel Announces Strategic Partnership with Al Manhal International Group of Abu Dhabi to Deploy Biosphere Facilities 2
(Date:11/24/2009)... protein that may help gut bacteria bind to the ga... probiotic producers to identify strains that are ...tics need to interact with cells lining the gut to...urfaces in the gut they are more likely to stick a...r Nathalie Juge from the Institute of Food Researc...
(Date:11/24/2009)...emarkable class of ring-shaped protein motors has ...rkeley National Laboratory (Berkeley Lab) using a ...at the Advanced Light Source (ALS). These protein ...eplication, and are vital to the survival of all b...h as the human papillomavirus, which has been link...
(Date:11/24/2009)...mber 24, 2009) -- The Wildlife Conservation Societ...e last remaining population of Siberian tigers has...ide of poaching and habitat loss. , ...ials of what needs to be done to protect remaining... The report was released by the Siberian Ti...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Report shows dramatic decline in Siberian tigers 2National Jewish Health Named Top Respiratory Hospital for 12th Consecutive Year 51906 1National Jewish Health Named Top Respiratory Hospital for 12th Consecutive Year 51906 2avVaa World Health Care Products Inc Announces Web Site Design for Neuroskin 28R 29 Psoriasis Relief DRTV Campaign 13064 1avVaa World Health Care Products Inc Announces Web Site Design for Neuroskin 28R 29 Psoriasis Relief DRTV Campaign 13064 2Water Street Healthcare Partners Acquires Pharmaceutical Development Business From AAIPharma Inc 51898 1Water Street Healthcare Partners Acquires Pharmaceutical Development Business From AAIPharma Inc 51898 2Water Street Healthcare Partners Acquires Pharmaceutical Development Business From AAIPharma Inc 51898 3
...ic fields from cell phones excite the brain cortex...ndividuals with epilepsy, or other neurological co...eurology, a journal by John Wiley & Sons. The ...ience (www.interscience.wiley.com/journal/ana). , ... phones which emit electromagnetic fields (EMFs). ...
...vered enzyme inhibitor, identified by researchers ...ay lead to pain relief for sufferers of arthritis ...t the University of California, Davis. The finding...s the most important discovery in inflammation in ...associated with the painkiller, Vioxx. , Lead aut...
...national scientific effort was launched last week ... rice production and avoid potential rice shortage...working on different aspects of the approach since...he sequencing of the rice genome is allowing resea...t work together to completely reconfigure what,s k...
Other Biology News:Cell phone emissions excite the brain cortex 2Pest control research leads to pain control discovery 2Pest control research leads to pain control discovery 3A more powerful and efficient engine for rice: the C3-C4 challenge 2
VZV IgM ELISA Kit, Single from Bio-Quant Inc.
...tom siRNA service provides the premium quality siR...tom siRNAs can be readily ordered online by provid...roviding the sense and antisense siRNA sequences. ...lencer Pre-designed siRNAs, which are already desi...
Bovine Serum Albumin from Equitech-Bio
Rabbit Anti-MPV17 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Biology Products: